QNCX
Price
$1.82
Change
+$0.04 (+2.25%)
Updated
Jul 11 closing price
Capitalization
94.9M
29 days until earnings call
VRCA
Price
$0.81
Change
-$0.06 (-6.90%)
Updated
Jul 11 closing price
Capitalization
74.6M
29 days until earnings call
Interact to see
Advertisement

QNCX vs VRCA

Header iconQNCX vs VRCA Comparison
Open Charts QNCX vs VRCABanner chart's image
Quince Therapeutics
Price$1.82
Change+$0.04 (+2.25%)
Volume$494.9K
Capitalization94.9M
Verrica Pharmaceuticals
Price$0.81
Change-$0.06 (-6.90%)
Volume$445.77K
Capitalization74.6M
QNCX vs VRCA Comparison Chart in %
Loading...
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRCA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
QNCX vs. VRCA commentary
Jul 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QNCX is a Hold and VRCA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2025
Stock price -- (QNCX: $1.82 vs. VRCA: $0.81)
Brand notoriety: QNCX and VRCA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: QNCX: 170% vs. VRCA: 91%
Market capitalization -- QNCX: $94.9M vs. VRCA: $74.6M
QNCX [@Biotechnology] is valued at $94.9M. VRCA’s [@Biotechnology] market capitalization is $74.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QNCX’s FA Score shows that 0 FA rating(s) are green whileVRCA’s FA Score has 0 green FA rating(s).

  • QNCX’s FA Score: 0 green, 5 red.
  • VRCA’s FA Score: 0 green, 5 red.
According to our system of comparison, QNCX is a better buy in the long-term than VRCA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QNCX’s TA Score shows that 4 TA indicator(s) are bullish while VRCA’s TA Score has 5 bullish TA indicator(s).

  • QNCX’s TA Score: 4 bullish, 4 bearish.
  • VRCA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VRCA is a better buy in the short-term than QNCX.

Price Growth

QNCX (@Biotechnology) experienced а +13.04% price change this week, while VRCA (@Biotechnology) price change was +14.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +13.15%. For the same industry, the average monthly price growth was +23.60%, and the average quarterly price growth was +32.61%.

Reported Earning Dates

QNCX is expected to report earnings on Nov 13, 2025.

VRCA is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+13.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QNCX($94.9M) has a higher market cap than VRCA($74.6M). VRCA YTD gains are higher at: 15.229 vs. QNCX (-2.674). QNCX has higher annual earnings (EBITDA): -40.25M vs. VRCA (-55.56M). QNCX has more cash in the bank: 31.6M vs. VRCA (29.6M). QNCX has less debt than VRCA: QNCX (15.8M) vs VRCA (42.4M). VRCA has higher revenues than QNCX: VRCA (7.18M) vs QNCX (0).
QNCXVRCAQNCX / VRCA
Capitalization94.9M74.6M127%
EBITDA-40.25M-55.56M72%
Gain YTD-2.67415.229-18%
P/E RatioN/AN/A-
Revenue07.18M-
Total Cash31.6M29.6M107%
Total Debt15.8M42.4M37%
FUNDAMENTALS RATINGS
QNCX vs VRCA: Fundamental Ratings
QNCX
VRCA
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
95
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
3641
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
28n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QNCX's Valuation (49) in the Biotechnology industry is somewhat better than the same rating for VRCA (95) in the Pharmaceuticals Major industry. This means that QNCX’s stock grew somewhat faster than VRCA’s over the last 12 months.

QNCX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as VRCA (100) in the Pharmaceuticals Major industry. This means that QNCX’s stock grew similarly to VRCA’s over the last 12 months.

QNCX's SMR Rating (99) in the Biotechnology industry is in the same range as VRCA (100) in the Pharmaceuticals Major industry. This means that QNCX’s stock grew similarly to VRCA’s over the last 12 months.

QNCX's Price Growth Rating (36) in the Biotechnology industry is in the same range as VRCA (41) in the Pharmaceuticals Major industry. This means that QNCX’s stock grew similarly to VRCA’s over the last 12 months.

QNCX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VRCA (100) in the Pharmaceuticals Major industry. This means that QNCX’s stock grew similarly to VRCA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
QNCXVRCA
RSI
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 7 days ago
86%
Declines
ODDS (%)
Bearish Trend 28 days ago
90%
Bearish Trend 18 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
82%
Aroon
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRCA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NAUFF0.24N/A
+1.72%
Nevgold Corp.
GNGYF0.23N/A
N/A
Guangshen Railway Co. Ltd.
ASCS5600.00N/A
N/A
American Crystal Sugar Co.
OILSF1.57N/A
-0.25%
Saturn Oil & Gas Inc.
RNLSY9.56-0.20
-2.05%
Renault SA

VRCA and

Correlation & Price change

A.I.dvisor tells us that VRCA and PBYI have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VRCA and PBYI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRCA
1D Price
Change %
VRCA100%
-7.55%
PBYI - VRCA
32%
Poorly correlated
-3.69%
ACOG - VRCA
30%
Poorly correlated
-1.68%
SLNO - VRCA
29%
Poorly correlated
+1.55%
FGEN - VRCA
29%
Poorly correlated
-2.72%
QURE - VRCA
27%
Poorly correlated
-3.23%
More